Bio-IT World April 12, 2019
Like any new technology, blockchain must find its place. Richard Shute believes that one of those places is in the life sciences, where it can benefit researchers and drug companies while protecting patients. Blockchain has great potential within the clinical arena to support enhanced data management at nearly every level, he said.
Shute is a project manager & consultant for The Pistoia Alliance, a global not-for-profit consortium of life science, pharma, technology, and academic organizations working to overcome barriers to R&D through collaboration. Shute has over 25 years of experience in Big Pharma, having worked at ICI, Zeneca, and AstraZeneca, and since 2015 he has been a consultant at Curlew Research and has been an advocate of blockchain technology.
On...
Today's Sponsors
Today's Sponsor